Aquestive Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Aquestive Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Aquestive Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Aquestive Therapeutics Inc. is AQST:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Aquestive Therapeutics Inc. has its primary listing on NASDAQ. You can trade Aquestive Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Aquestive Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Aquestive Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Aquestive Therapeutics Inc. or others.